Laurus Labs Secures USFDA EIR for API Facility, Enhancing Global Compliance

Unknown Apr 02, 2026 400 Views

Laurus Labs Limited has been issued the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its active pharmaceutical ingredient (API) facility in Visakhapatnam, Andhra Pradesh. This achievement reaffirms the focus of the company on regulatory com...